Cresset Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.07M Buy
63,790
+2,054
+3% +$228K 0.03% 297
2025
Q1
$6.92M Sell
61,736
-15,218
-20% -$1.71M 0.03% 292
2024
Q4
$7.11M Sell
76,954
-74,671
-49% -$6.9M 0.03% 284
2024
Q3
$12.7M Buy
151,625
+24,013
+19% +$2.01M 0.05% 248
2024
Q2
$8.76M Buy
127,612
+31,695
+33% +$2.17M 0.04% 304
2024
Q1
$7.03M Buy
95,917
+916
+1% +$67.1K 0.03% 318
2023
Q4
$7.7M Buy
95,001
+4,898
+5% +$397K 0.05% 252
2023
Q3
$6.75M Sell
90,103
-7,038
-7% -$527K 0.03% 253
2023
Q2
$7.49M Buy
97,141
+78,956
+434% +$6.09M 0.01% 231
2023
Q1
$1.51M Sell
18,185
-3,556
-16% -$295K 0.03% 266
2022
Q4
$1.47M Sell
21,741
-923
-4% -$62.6K 0.02% 241
2022
Q3
$1.4M Sell
22,664
-1,904
-8% -$117K 0.02% 277
2022
Q2
$1.51M Sell
24,568
-507
-2% -$31.2K 0.02% 275
2022
Q1
$1.49M Sell
25,075
-15,414
-38% -$916K 0.02% 313
2021
Q4
$2.94M Sell
40,489
-95
-0.2% -$6.9K 0.03% 231
2021
Q3
$2.84M Buy
40,584
+7,094
+21% +$496K 0.04% 175
2021
Q2
$2.31M Buy
33,490
+10,347
+45% +$712K 0.03% 183
2021
Q1
$1.5M Buy
23,143
+2,679
+13% +$173K 0.02% 217
2020
Q4
$1.19M Sell
20,464
-4,652
-19% -$271K 0.02% 214
2020
Q3
$1.59M Sell
25,116
-1,823
-7% -$115K 0.03% 179
2020
Q2
$2.07M Buy
26,939
+8,035
+43% +$616K 0.05% 145
2020
Q1
$1.41M Buy
18,904
+7,184
+61% +$537K 0.04% 146
2019
Q4
$762K Buy
11,720
+3,429
+41% +$223K 0.02% 243
2019
Q3
$525K Buy
8,291
+1,283
+18% +$81.2K 0.02% 264
2019
Q2
$473K Sell
7,008
-3,614
-34% -$244K 0.01% 255
2019
Q1
$691K Sell
10,622
-611
-5% -$39.7K 0.03% 147
2018
Q4
$703K Buy
+11,233
New +$703K 0.04% 98